Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, announced today the enrollment ...

The state of the world has been looking dark. Helping our fellow human beings is one way to add some light.

Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity (R) Percutaneous AVF System The Velocity System is a next generation percutaneous AVF technology designed ...

Women with inflammatory bowel disease (IBD) are three times more likely to forgo having children than people without the ...

Jarryd Nurden is opening up about the terrifying and life-altering health crisis that nearly ended his career and cost him ...

Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

RESEARCH presented at UEG Week 2025 revealed how Westernised diets, which are rich in fat and sugar but low in fibre, can ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

Introduction Photobiomodulation (PBM) has shown promising effects in managing postoperative pain following conventional periapical surgery, although current evidence remains limited. This study aims ...